Skip to main content

Table 2 Factors associated with IPT uptake

From: Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study

Variable

IPT uptake

PR (95% CI)

P Value

Yes (N = 152) n (%)

No (N = 73) n (%)

Gender

 Male

85 (65.0)

33 (35.0)

1.15(0.95–1.38)

0.136

 Female

67(62.0)

40 (38.0)

1

Age categories

  < 3 years

8 (36.0)

14 (64.0)

1

 Between 3- > 5 years

14 (45.0)

17 (55.0)

1.24 (0.63–2.44)

0.539

 5- < 10 years

121 (70.0)

52 (30.0)

1.92 (1.09–3.37)

0.003

Latest viral load

 Virally suppressed

128 (71.0)

53 (29.0)

1.06 (0.80–1.41)

0.663

 Not suppressed

18 (67.0)

9 (33.0)

1

 Not documented

6 (35.0)

11 (65.0)

History of TB treatment

 Yes

15 (60.0)

10 (40.0)

1

 No

137 (69.0)

63 (31.0)

1.14 (0.82–1.59)

0.401

Baseline WHO HIV staging

 1

65 (73.9)

23 (26.1)

1

 2

38 (60.3)

25 (39.7)

0.81 (0.64–1.03)

0.083

 3

35 (74.5)

12 (25.5)

1.01 (0.82–1.24)

0.948

 4

6 (50.0)

6 (50.0)

1.4 (0.29–6.8)

0.67

 Not documented

8 (53.3)

7 (46.7)